The life sciences customer engagement model has changed dramatically over the past decade, especially in Canada.
Today’s life sciences companies operate in dynamic markets characterized by more specialized portfolios, cost pressures, changing regulation, financial uncertainty and a shorter timeframe to commercialize products. Interacting with HCPs requires a coordinated team effort between marketing and sales functions at a minimum. HCPs expect relevant, informative communications with pharmaceutical and medical device manufacturers. Sales teams require real time visibility on other teams that engage with their accounts.
Orchestration of the entire buying process requires a new generation of solutions and a shift from siloed execution. There is urgency within the market for more sophisticated customer engagements against a backdrop of an orchestrated commercial model.
In this webinar, learn about what is true orchestrated customer engagement (OCE), why you should consider OCE for the Canadian market, and how to futureproof your sales force.
*** This session is only open to pharmaceutical companies (or their industry associations). Others interested in this topic, should contact IQVIA directly.***